Skip to main content

180 Life Sciences Corp. (ATNF)

NASDAQ: ATNF · Delayed Price · USD
5.64
+0.10 (1.81%)
After-hours:Sep 24, 2021 7:56 PM EDT
5.54
-0.31 (-5.30%)
At close: Sep 24, 4:00 PM
Market Cap187.06M
Revenue (ttm)n/a
Net Income (ttm)-46.01M
Shares Out33.77M
EPS (ttm)-2.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume897,930
Open5.70
Previous Close5.85
Day's Range5.48 - 5.85
52-Week Range1.90 - 13.05
Betan/a
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About ATNF

180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The comp...

IndustryBiotechnology
Founded2016
Stock ExchangeNASDAQ
Ticker SymbolATNF
Full Company Profile

Financial Performance

Financial Statements

News

Celltrion Healthcare and 180 Life Sciences Enter Into Memorandum of Understanding for a Supply Agreement for the Ongo...

Three Anti-TNF Product Candidates To Be Included in Expected Global Agreement Three Anti-TNF Product Candidates To Be Included in Expected Global Agreement

6 days ago - GlobeNewsWire

180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders

PALO ALTO, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b clinical trial, fo...

3 weeks ago - GlobeNewsWire

180 Life Sciences Corp. Announces Closing of $15.0 Million Private Placement

PALO ALTO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the "Company"), a clinical-stage biotechnology company focused on the development of n...

1 month ago - GlobeNewsWire

Why 180 Life Sciences Stock Is Falling Today

Another capital raise less than a year after the company's stock market debut is more than a little troubling.

1 month ago - The Motley Fool

180 Life Sciences Corp. Announces $15.0 Million Private Placement

PALO ALTO, Calif., Aug. 19, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of nov...

1 month ago - GlobeNewsWire

180 Life Sciences Announces Selection of Lead Synthetic CBD Analogue

Collaboration Between the Pioneer of Cannabis Chemistry in Israel, Professor Raphi Mechoulam, Sir Marc Feldmann's Laboratory in Oxford, and 180 Life Sciences Scientists, Identifies a Non-Psychoactive Ca...

1 month ago - GlobeNewsWire

180 Life Science Corp Nears Key Levels And Could Breakout Soon

180 Life Sciences Corp (NASDAQ: ATNF) shares are trading higher Monday after the company announced it regained compliance with the Nasdaq. The company was notified Jan. 6 it did not meet the listing req...

2 months ago - Benzinga

180 Life Sciences Regains Nasdaq Compliance for Listing Rules 5605(b)(1) and 5605(c)(2)

MENLO PARK, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of ...

2 months ago - GlobeNewsWire

180 Life Sciences Joins Russell Microcap® Index

MENLO PARK, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of ...

2 months ago - GlobeNewsWire

180 Life Sciences Files Plan with Nasdaq Related to Delayed Quarterly Report on Form 10-Q and Form 10-K

Company Granted Extension Until July 31, 2021, to Regain Compliance Company Granted Extension Until July 31, 2021, to Regain Compliance

2 months ago - GlobeNewsWire

180 Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD and Frank Knuettel II, MBA to Board of Direc...

MENLO PARK, Calif., June 10, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of no...

3 months ago - GlobeNewsWire

180 Life Sciences Corp. to Present at LD Micro Invitational XI

Management to Present Thursday June 10th Management to Present Thursday June 10th

3 months ago - GlobeNewsWire

180 Life Sciences Corp. Announces the Appointment of Russell T. Ray, MBA and Teresa DeLuca MD, MBA to Board of Directors

MENLO PARK, Calif., May 28, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of nov...

3 months ago - GlobeNewsWire

180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report on Form 10-Q

MENLO PARK, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of n...

4 months ago - GlobeNewsWire

180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Annual Report on Form 10-K

MENLO PARK, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the "Company"), a clinical-stage biotechnology company focused on the development of...

5 months ago - GlobeNewsWire

7 Reddit Penny Stocks to Buy for a Biotech Boom

So, which biotech penny stocks, popular with the Reddit set, offer such opportunity? Consider these seven as ones with potential to live up to online enthusiasm.

5 months ago - InvestorPlace

180 Life Sciences Corp. Congratulates Dr. Lynn Williams on International Dupuytren Award 2021

Company actively pursuing Collagen VI pathway identified in peer-reviewed publication Company actively pursuing Collagen VI pathway identified in peer-reviewed publication

5 months ago - GlobeNewsWire

What's Happening With ATNF Stock And CELC Stock?

180 Life Sciences Corp (NASDAQ: ATNF) shares are trading higher following insider buying from Marc Feldmann, a director on the company's board, and Jonathan Rothbard, the company's chief scientific offi...

Other symbols:CELC
5 months ago - Benzinga

Why Ikena Oncology, Evelo Biosciences And 180 Life Sciences Are Rallying Today

Ikena Oncology, Inc. (NASDAQ: IKNA), 180 Life Sciences Corp. (NASDAQ: ATNF) and Evelo Biosciences, Inc. (NASDAQ: EVLO) are among the major biopharma movers of Monday. Ikena Oncology Gains On Fund Buying...

Other symbols:IKNAEVLO
5 months ago - Benzinga

5 Reddit Penny Stocks Seeing the Most Chatter Friday

Reddit penny stocks continue to be a hot subject among retail investors and we're looking at the most-talked-about ones today. The post 5 Reddit Penny Stocks Seeing the Most Chatter Friday appeared firs...

Other symbols:CGCCTRMCTXRZOM
5 months ago - InvestorPlace

DISCB and 6 Other Reddit Stocks Waiting for a Short Squeeze

Reddit stocks continue to have the public's attention. These 7 could be the next short squeeze targets based on technical signs.

5 months ago - InvestorPlace

180 Life Science Rallies 18%: Technical Levels To Watch

180 Life Sciences Corp. (NASDAQ: ATNF) shares rallied Friday, and there was no company evident news to explain the rise in shares. The stock closed up 18.5% at $6.96.

6 months ago - Benzinga

ATNF Stock: Why 180 Life Sciences Is Soaring Higher Today

ATNF stock is soaring today, as investors digest a recent intriguing podcast the company released highlighting its long-term plans. The post ATNF Stock: Why 180 Life Sciences Is Soaring Higher Today app...

6 months ago - InvestorPlace

180 Life Sciences Corp. (NASDAQ: ATNF) Recognized R&D Pioneers in Anti-Inflammatory Therapeutics

NEW YORK, March 26, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – 180 Life Sciences Corp. (NASDAQ: ATNF) announces the availability of a broadcast titled, “Controlling Inflammation to Stop Disease.”

6 months ago - GlobeNewsWire

180 Life Sciences Corp. (NASDAQ: ATNF) in Hot Pursuit of New Anti-Inflammatory Blockbusters

NEW YORK, March 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — 180 Life Sciences Corp. (NASDAQ: ATNF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trus...

6 months ago - GlobeNewsWire